Abstract Details
Activity Number:
|
371
|
Type:
|
Contributed
|
Date/Time:
|
Tuesday, August 11, 2015 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #317032
|
View Presentation
|
Title:
|
Robust Bayesian Dose-Finding Design for Phase I/II Clinical Trials
|
Author(s):
|
Suyu Liu* and Valen E. Johnson
|
Companies:
|
MD Anderson Cancer Center and Texas A&M University
|
Keywords:
|
Adaptive design ;
Bayesian method ;
PhaseI/II trial
|
Abstract:
|
We propose a Bayesian phase I/II dose-finding trial design that simultaneously accounts for toxicity and efficacy. We model the toxicity and efficacy of investigational doses using a flexible Bayesian dynamic model, which borrows information across doses without imposing stringent parametric assumptions on the shape of the dose-toxicity and -efficacy curves. An intuitive utility function that reflects the desirability trade-offs between efficacy and toxicity is used to guide the dose assignment and selection. We also discuss the extension of this design to handle delayed toxicity and efficacy. We conduct extensive simulation studies to examine the operating characteristics of the proposed method under various practical scenarios. The results show that the proposed design possesses good operating characteristics and is more robust to the shape of the dose-toxicity and -efficacy curves than other phase I/II designs.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2015 program
|
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.